NTT-CORPORATION
NTT Corporation (“NTT”) screened the “International Conference for Visualizing our Future brought about by Technological Innovation feat. IOWN” at the Short Shorts Film Festival & Asia 2022 (SSFF & Asia 2022), one of the largest international short film festivals in Asia recognized by the U.S. Academy Awards. The conference featured a discussion between NTT, experts of various fields, and international directors who have won the Grand Prix at SSFF & Asia about a vision of the future influenced by technological innovation like IOWN1 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220721005622/en/
After filmmakers from around the world watched the screening, NTT issued a call for short films featuring the theme of our ideal lives created alongside scientific and technological innovation. From the entries, we will create one short film that best captures the theme.
You can watch the conference on the official SSFF & Asia 2022 website .
NTT is working toward the realization of a smart society founded on IOWN, which is the next-generation communication platform. In November 2021, we founded the Natural Society Lab to communicate how the technology incorporating IOWN will benefit society and enrich people's lives. We also create short films to convey to the masses our vision of a world where innovation in science and technology flourish alongside ideal human life.
Experts and filmmakers that took part in the conference included the Yubari International Fantastic Film Festival Executive Producer and Shinichiro Kumagaya, a professor from the Research Center for Advanced Science and Technology at the University of Tokyo. The conference included discussions on the following four topics:
Part 1: What is "Natural Society Lab"?
Part 2: Natural Society Lab & Daily Life - in the Context of Film & Science
Part 3: Creators' Take on Visualizing Thought
Part 4: Expressing the World Realized by IOWN
Conference Speakers:
Akiko Kudo
NTT Senior Vice President
Head of Public Relations
and Deputy Head of Business strategy*
*2022.June
Junji Watanabe
NTT Communication Science Laboratories
Senior Distinguished Research Scientist
Shinichiro Kumagaya
Pediatrician and
Associate Professor at the Research Center
for Advanced Science and Technology
Shuichi Fukatsu
Executive Producer
for Yubari International Fantastic Film Festival
Kristof Deak
Filmmaker
Genevieve Clay-Smith
Filmmaker
The short films selected and produced through the competition will be released next year.
1
IOWN (Innovative Optical and Wireless Network)
A future communication platform utilizing cutting-edge optical-related technology and information processing technology to realize a smart world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220721005622/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release
The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release
Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release
Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve
Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release
Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
